Cell Culture Technology– category –
-
AGC Biologics: Job Posting Reveals Broad Biomanufacturing Scope, Spanning Proteins to Gene Therapies
Myworkdayjobs.com USA Overview A recent student assistant job posting from AGC Biologics has inadvertently showcased the company's remarkably extensive Contract Development and Manufacturing Organization (CDMO) capabilities. The company ... -
Miltenyi Biotec’s CliniMACS Prodigy® Automates TIL Expansion, Paving Way for Scalable Cancer Immunotherapy
Bioprocess Online Germany Overview Miltenyi Biotec is advancing the automated expansion of tumor-infiltrating lymphocytes (TILs) using its GMP-compliant CliniMACS Prodigy® platform. This system addresses critical challenges in scaling up... -
Allogeneic Cell Therapy Manufacturing: Broad Applicability, Scalability, and Automation Driving Future Advances
Industry Informational Article USA Overview This article provides a comprehensive overview of allogeneic cell therapy manufacturing, highlighting its advantages over autologous approaches, including broader applicability, superior scalab... -
Liv Hospital Highlights Off-the-Shelf Allogeneic CAR-T Manufacturing for Enhanced Accessibility via Standardized Donor Cells
Liv Hospital Turkey Overview Liv Hospital is championing the development of allogeneic CAR-T cell manufacturing as an 'off-the-shelf' solution, leveraging standardized donor cells to significantly improve treatment accessibility. This ad... -
Scaling the Future of Medicine: RoosterBio and Applied StemCell Partner on iPSC Bioprocess Solutions
PRNewswire USA Overview RoosterBio and Applied StemCell have announced a strategic partnership aimed at advancing scalable induced pluripotent stem cell (iPSC)-based bioprocess solutions. This collaboration integrates Applied StemCell's ... -
CDMOs Accelerate GLP-1 Manufacturing, Outpacing Traditional Facility Builds to Meet Soaring Demand
Pharma Advancement USA Overview Contract Development and Manufacturing Organizations (CDMOs) are rapidly scaling their manufacturing capabilities for GLP-1 receptor agonists, providing quicker solutions than ground-up facility constructi... -
July 2026 Pharma M&A Review Highlights Manufacturing Partnerships and AI Innovation as Key Trends, Featuring Major Investments by Lonza, AGC Biologics, and Evonik
Biospectrum Jobs India Overview A July 2026 review of pharmaceutical M&A activities identifies manufacturing partnerships and AI innovation as critical emerging trends. Key players like Lonza expanded biopharmaceutical alliances, AGC... -
Chime Biologics Unveils AI-Driven Biomanufacturing Future with New Wuhan GMP-2 Facility and 100+ Bioreactor Megafactory Vision
BioPharma APAC China Overview Chime Biologics has significantly bolstered its biopharmaceutical manufacturing capabilities with the opening of its GMP-2 facility in Wuhan, China, equipped with eight Cytiva 2,000-liter single-use Xcellere... -
Pioneering Off-the-Shelf Immunotherapy: CellFiber and Tidewave Bio Partner on Scalable 3D Cell Culture Manufacturing
BioSpace Japan Overview CellFiber and Tidewave Bio have launched a collaborative research program to evaluate CellFiber's proprietary 3D cell encapsulation technology for scalable immune cell manufacturing. This proof-of-concept study, l... -
AI-Powered Biologics: AstraZeneca and CSPC Forge Strategic Manufacturing Alliance in China
Fierce Pharma China Overview AstraZeneca and CSPC Pharmaceutical have formed a joint venture to establish a new biopharmaceutical manufacturing facility in Shijiazhuang, China. CSPC will contribute AI-driven GMP systems and manufacturing...
